| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Lynch Casey is a Chief Executive Officer at Quince Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 25 sells.
Estimated insider holdings value: $104K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2021 | QNCX Quince Therapeutics, Inc. | Chief Executive Officer | Sell | 30,000 | $34.58 | $1,037,360.76 | -0.8% | +195.6% | -88.9% | |
| Mar 22, 2021 | QNCX Quince Therapeutics, Inc. | Chief Executive Officer | Sell | 30,000 | $35.59 | $1,067,610.75 | -0.7% | +56.0% | -82.9% | |
| Feb 3, 2021 | QNCX Quince Therapeutics, Inc. | Chief Executive Officer | Sell | 60,000 | $38.49 | $2,309,599.92 | -0.3% | - | - |